Faricimab

ATC S01LA09 · 11 markets · 23 records

Faricimab 11 markets · 23 records Forms

AU 5 records · 3 strengths

6 mg/0.05 mLinjectionVABYSMO also in SG·US
120 mg/mLinjectionVABYSMO faricimab 120 mg/mL solution for injection in a pre-filled syringe+1VABYSMO faricimab 120 mg/mL solution for injection vial unknown

Records without a stated strength · 1 VABYSMO

GB 2 records · 2 strengths

28.8 mg/0.24 mLinjectionVabysmo 28.8mg/0.24ml solution for injection vials
21 mg/0.175 mLinjectionVabysmo 21mg/0.175ml solution for injection pre-filled syringes

CA 2 records · 1 strengths

6 mgliquidVABYSMO

SG 2 records · 1 strengths

6 mg/0.05 mLinjectionVABYSMO SOLUTION FOR INJECTION 6MG/0.05ML+1VABYSMO SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 6MG/0.05ML also in AU·US

ES 2 records · 1 strengths

120 mg/1 mLinjectionVABYSMO+1VABYSMO PRECARGADA

HK 2 records · 1 strengths

Records without a stated strength · 1 VABYSMO SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 6MG/0.05ML、Vabysmo solution for intravitreal injection

US 1 records · 1 strengths

6 mg/0.05 mLinjectionVABYSMO also in AU·SG

CN 1 records · 1 strengths

0.05 mLliquid罗视佳法瑞西单抗

MX 1 records · 1 strengths

Records without a stated strength · 1 VABYSMO

TW 1 records · 1 strengths

Records without a stated strength · 1 Vabysmo solution for intravitreal injection、羅視萌注射劑

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 VABYSMO

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.